Blair Willette invests in early-stage science companies at KdT Ventures. Her pharmacology research at Duke focused on how the location of receptors within cells changes drug signaling.
Blair Willette invests in early-stage science companies at KdT Ventures. Her pharmacology research at Duke focused on how the location of receptors within cells changes drug signaling.